Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica D Schulz

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2019
Reply to NalinDavid Wimmersberger, Jessica D Schulz, Jennifer Keiser
Antimicrobial Agents and Chemotherapy|October 17, 2018
<i>In Vitro</i> and <i>In Vivo</i> Drug-Drug Interaction Study of the Effects of Ivermectin and Oxantel Pamoate on TribendimidineAnna Neodo, Jessica D Schulz, Jörg Huwyler, et al.
Trends in Parasitology|June 3, 2018
Preventive Chemotherapy in the Fight against Soil-Transmitted Helminthiasis: Achievements and LimitationsJessica D Schulz, Wendelin Moser, Eveline Hürlimann, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 29, 2015
Improving oral drug bioavailability with polycations?Jessica D Schulz, Marc A Gauthier, Jean-Christophe Leroux
Antimicrobial Agents and Chemotherapy|February 13, 2019
Pharmacokinetics of Albendazole, Albendazole Sulfoxide, and Albendazole Sulfone Determined from Plasma, Blood, Dried-Blood Spots, and Mitra Samples of Hookworm-Infected AdolescentsJessica D Schulz, Anna Neodo, Jean T Coulibaly, et al.
ACS Nano|February 3, 2012
PEG nanocages as non-sheddable stabilizers for drug nanocrystalsKathrin Fuhrmann, Jessica D Schulz, Marc A Gauthier, et al.
The Journal of Antimicrobial Chemotherapy|March 13, 2019
Pharmacokinetics of ascending doses of ivermectin in Trichuris trichiura-infected children aged 2-12 yearsJessica D Schulz, Jean T Coulibaly, Christian Schindler, et al.
Clinical Pharmacology and Therapeutics|April 18, 2019
Ivermectin Dosing Strategy to Achieve Equivalent Exposure Coverage in Children and AdultsJanneke M Brussee, Jessica D Schulz, Jean T Coulibaly, et al.
Eclinicalmedicine|May 15, 2020
Efficacy and safety of ascending dosages of albendazole against <i>Trichuris trichiura</i> in preschool-aged children, school-aged children and adults: A multi-cohort randomized controlled trialChandni Patel, Jean T Coulibaly, Jessica D Schulz, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2022
Pharmacokinetic modelling and simulation to optimize albendazole dosing in hookworm- or Trichuris trichiura-infected infants to adultsDaniela Hofmann, Janneke M Brussee, Jessica D Schulz, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2019
Reply to NalinDavid Wimmersberger, Jessica D Schulz, Jennifer Keiser
Antimicrobial Agents and Chemotherapy|October 17, 2018
<i>In Vitro</i> and <i>In Vivo</i> Drug-Drug Interaction Study of the Effects of Ivermectin and Oxantel Pamoate on TribendimidineAnna Neodo, Jessica D Schulz, Jörg Huwyler, et al.
Trends in Parasitology|June 3, 2018
Preventive Chemotherapy in the Fight against Soil-Transmitted Helminthiasis: Achievements and LimitationsJessica D Schulz, Wendelin Moser, Eveline Hürlimann, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 29, 2015
Improving oral drug bioavailability with polycations?Jessica D Schulz, Marc A Gauthier, Jean-Christophe Leroux
Antimicrobial Agents and Chemotherapy|February 13, 2019
Pharmacokinetics of Albendazole, Albendazole Sulfoxide, and Albendazole Sulfone Determined from Plasma, Blood, Dried-Blood Spots, and Mitra Samples of Hookworm-Infected AdolescentsJessica D Schulz, Anna Neodo, Jean T Coulibaly, et al.
ACS Nano|February 3, 2012
PEG nanocages as non-sheddable stabilizers for drug nanocrystalsKathrin Fuhrmann, Jessica D Schulz, Marc A Gauthier, et al.
The Journal of Antimicrobial Chemotherapy|March 13, 2019
Pharmacokinetics of ascending doses of ivermectin in Trichuris trichiura-infected children aged 2-12 yearsJessica D Schulz, Jean T Coulibaly, Christian Schindler, et al.
Clinical Pharmacology and Therapeutics|April 18, 2019
Ivermectin Dosing Strategy to Achieve Equivalent Exposure Coverage in Children and AdultsJanneke M Brussee, Jessica D Schulz, Jean T Coulibaly, et al.
Eclinicalmedicine|May 15, 2020
Efficacy and safety of ascending dosages of albendazole against <i>Trichuris trichiura</i> in preschool-aged children, school-aged children and adults: A multi-cohort randomized controlled trialChandni Patel, Jean T Coulibaly, Jessica D Schulz, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2022
Pharmacokinetic modelling and simulation to optimize albendazole dosing in hookworm- or Trichuris trichiura-infected infants to adultsDaniela Hofmann, Janneke M Brussee, Jessica D Schulz, et al.
Pageof 2